While the exact incidence is unknown, estimates range from 33 - 57 percent of patients staying in the ICU for longer than 7 days. More exact data is difficult to obtain, since variation exists in defining the condition. The three main risk factors for<unk>  and CIM are sepsis and systemic inflammatory response syndrome (SIRS), and multi-organ failure. Reported rates of<unk> /CIM in people with sepsis and SIRS range from 68 to 100 percent. Additional risk factors for developing<unk> /CIM include: female gender, high blood sugar (hyperglycemia), low serum albumin, and immobility. A greater severity of<unk>  increases the risk of<unk> /CIM. Such risk factors include: multi-organ dysfunction, kidney failure, renal replacement therapy, duration of organ dysfunction, duration of ICU stay, and central neurologic failure. Certain medications are associated with<unk> /CIM, such as corticosteroids, neuromuscular blocking agents, vasopressors, catecholamines, and intravenous nutrition (parenteral nutrition). Research has produced inconsistent results for the impact of hypoxia, hypotension, hyperpyrexia, and increased age on the risk of<unk> /CIM. The use of aminoglycosides is not an independent risk for the development of<unk> /CIM.
Critical illness polyneuropathy
Tropical neuropathy
Alcoholic polyneuropathy
Chronic inflammatory demyelinating polyneuropathy
Diabetic neuropathy
Peripheral mononeuropathy
Vasculitic neuropathy
MGUS polyneuropathy